See also
Arbovirus
List of diseases spread by invertebrates
List of insect-borne diseases
Mobovirus
Mosquito-borne disease
Robovirus
Sandfly-borne disease
Tibovirus
Ticks of domestic animals

References
External links

Tick-Borne Diseases: Recommendations for Workers and Employers—National Institute for Occupational Safety and Health
Tickborne Diseases—National Center for Infectious Diseases (CDC)
Tickborne Disease Website—Massachusetts Department of Public Health
Ixodes Scapularis—3D animation of Deer or Blacklegged Tick from US Army site
Parasitic Insects, Mites and Ticks: Genera of Medical and Veterinary Importance Wikibooks
The trials were conducted in the United States and Canada.Trial 1 enrolled subjects 1 to 20 years old who were recently diagnosed with ALL or lymphoblastic lymphoma. Subjects received calaspargase pegol-mknl or pegaspargase (a drug that helps convert asparagine to other substances) as part of a combination of drugs used for treatment of ALL. The trial had 2 phases. Subjects received calaspargase pegol-mknl or pegaspagase intravenously on Day 7 of the first phase. Subjects received either calaspargase pegol-mknl intravenously every 3 weeks for 10 doses or pegaspargase intravenously every 2 weeks for 15 doses during the second phase. The benefit of calaspargase pegol-mknl was assessed by measuring the activity level of asparginase in the blood on Days 7, 11, 18, 25, and 32 of the first phase and comparing it to pegaspargase.Trial 2 enrolled subjects 1 to 18 years old who were recently diagnosed with high-risk ALL. Subjects received one of 2 doses of calaspargase pegol-mknl or pegaspargase intravenously as part of a combination of drugs used for treatment. Subjects received calaspargase pegol-mknl or pegaspargase on Day 4 of the first phase and Days 2 and 22 of the second phase. Subjects received up to 12 doses of calaspargase pegol-mknl or pegaspargase intravenously depending on the bone marrow response. The benefit of calaspargase pegol-mknl was assessed by measuring the concentration of drug in the body over 25 days (AUC) and the maximum amount of drug in the blood after a single dose (Cmax).